Live Chat

NuvaRing Discontinuation Rate Raises Questions

NuvaRing, a heavily marketed and widely distributed contraceptive vaginal ring, was approved by the Food and Drug Administration (FDA) in 2001 and is used by more than 1,000,000 women worldwide. Recent studies, however, suggest that NuvaRing’s benefits are not without potentially serious side effects.


NuvaRing patients in two clinical studies discontinued NuvaRing use at a rate of just over 15 percent, citing adverse events. While some adverse events are relatively minor, like headaches, others are more serious. In fact, some patients have experienced cardiovascular issues such as stroke and heart attack.


Want to know more about the legal consequences of your NuvaRing adverse events? The attorneys at the Dallas law firm of Fears Nachawati are prepared to answer your questions and advise you and your family on your potential next steps. For your free consultation, call us at 1.866.545.8364 or email

Drug Litigation

NuvaRing Discontinuation Rate Raises Questions